To the best of the authors’ knowledge, this is the first comprehensive study to have shown that CLCP-1 and CLCP-2 exhibit a potent protective effect against H. pylori-infected gastric adenocarcinoma cells. Here, CLCP2 is linked to gastric adenocarcinoma.